Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019

By sjmartinez • March 18, 2025

Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup Røge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC. Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. J Infect Dis. 2025 Mar 17;231(3):677-683. doi: 10.1093/infdis/jiae452. PMID: 39269490; PMCID: PMC11911911.

Tags: antibody tests, biomarkers, covid-19, Harbor UCLA, Infectious Diseases, personalized medicine, point-of-care tests, Publications

Opportunistic AI-derived adiposity measures from coronary artery calcium scans predict new-onset type 2 diabetes in adults without obesity or hyperglycemia: insights from the AI-CVD study within MESA

Naghavi M, Azimi A, Atlas K, Reeves AP, Zhang C, Wasserthal J, Mirjalili SR, Mozafarybazargany M, Hashemi A, Atlas T, Henschke CI, Yankelevitz DF, Mechanick[...]

Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in Los Angeles County

Lee PS, OYong K, Shah AN, Thiel C, LeBrun M, Miller LG, Rubin Z. Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus[...]

SPIROMICS HF: Rationale, Design, and Reproducibility of Measures

Barr RG, Lima JAC, Prince MR, Ambale Venkatesh B, Abraham T, Agarwal PP, Arora G, Balasubramanian A, Barjaktarevic I, Bello NA, Bluemke DA, Budoff MJ,[...]